CTOs on the Move

Ocular Therapeutix

www.ocutx.com

 
Founded in 2006, Ocular Therapeutix is a fast-growing, aspiring leader in the biopharmaceutical industry. The company has a clear vision – to improve current therapeutic options in ophthalmology by encapsulating previously approved therapeutic agents in our novel hydrogel to provide a sustained delivery of drugs to the eye. We are reframing the industry with new modalities for ophthalmic therapies. As a small company, our employees are provided the unique opportunity to help build the foundation of the business as it grows. We strongly believe that our success is contingent upon the achievements of our employees. We strive to create a ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.ocutx.com
  • 34 Crosby Drive Ste 105
    Bedford, MA USA 01730
  • Phone: 781.357.4000

Executives

Name Title Contact Details
Steve Fedan
Director of Information Technology Profile

Funding

Ocular Therapeutix raised $35.1M on 01/30/2018

Similar Companies

CBD Ophthalmic/Tomey

CBD Ophthalmic/Tomey is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Remedent

Remedent is a El Segundo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

D-Sharp Dental

D-Sharp Dental Inc. is a Burlington, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medstrat

Medstrat is a Downers Grove, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Median Technologies

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.